Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Continuous Flow Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111689969A details a streamlined sildenafil synthesis reducing reaction times and eliminating intermediate isolation for cost-effective API manufacturing.
Eliminate metal catalysts and inert gas requirements in quinoline synthesis. Our CDMO expertise ensures scalable, green production for antimalarial drugs and PDE4 inhibitors.
Solve high-cost, low-yield issues in tegrazan intermediate production. New route achieves ≥99% purity with simplified steps and 100kgs+ scale capability.